Tamaoka A, Kalaria R N, Lieberburg I, Selkoe D J
Department of Neurology, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1345-9. doi: 10.1073/pnas.89.4.1345.
Altered proteolysis of the beta-amyloid precursor protein (beta APP) resulting in release of the approximately 40-residue amyloid beta-protein (A beta P) may be a seminal pathogenetic event in Alzheimer disease. Using region-specific beta APP antibodies, we searched for stable proteolytic intermediates containing the intact A beta P region in brain tissue. A 22-kDa beta APP fragment was selectively detected in microvessels purified from cerebral cortex and other brain regions. On immunoblots, the 22-kDa band is labeled by five distinct antisera to beta APP carboxyl-terminal peptides and by affinity-purified antibodies to the recombinant proteins beta APP444-592 and beta APP592-695, which flank the A beta P region. The protein is virtually undetectable in whole-brain homogenates or microvessel-free fractions of brain. The protein is extractable from microvessels in Triton X-100 and other detergents, indicating its membrane association. In comparison with cortical microvessels, microvessels purified from white matter, cerebellum, and nonneural tissues contain lower amounts of the 22-kDa protein. The protein is found in microvessels of both normal and Alzheimer disease brains and occurs in low amounts in microvessels from fresh bovine brain. The size and specific immunoreactivity of the 22-kDa protein indicate that it is a stable fragment of beta APP containing the intact A beta P. The occurrence of this potentially amyloidogenic intermediate in microvessels is consistent with a vascular or hematogenous origin for some A beta P deposits in Alzheimer disease.
β-淀粉样前体蛋白(βAPP)的蛋白水解改变导致约40个残基的淀粉样β蛋白(AβP)释放,这可能是阿尔茨海默病发病机制中的一个关键事件。我们使用区域特异性βAPP抗体,在脑组织中寻找含有完整AβP区域的稳定蛋白水解中间体。在从大脑皮层和其他脑区纯化的微血管中选择性检测到一个22 kDa的βAPP片段。在免疫印迹上,22 kDa条带被五种针对βAPP羧基末端肽的不同抗血清以及针对重组蛋白βAPP444 - 592和βAPP592 - 695的亲和纯化抗体标记,这两种重组蛋白位于AβP区域两侧。在全脑匀浆或无微血管的脑部分中几乎检测不到该蛋白。该蛋白可在Triton X - 100和其他去污剂中从微血管中提取,表明其与膜相关。与皮质微血管相比,从白质、小脑和非神经组织纯化的微血管中22 kDa蛋白的含量较低。在正常和阿尔茨海默病大脑的微血管中都发现了该蛋白,新鲜牛脑微血管中含量较低。22 kDa蛋白的大小和特异性免疫反应性表明它是含有完整AβP的βAPP稳定片段。这种潜在的淀粉样生成中间体在微血管中的出现与阿尔茨海默病中一些AβP沉积物的血管或血源性起源一致。